OTCMKTS:CCEL

Cryo-Cell International Stock Forecast, Price & News

$9.80

+0.20 (+2.08 %)

(As of 03/3/2021 12:00 AM ET)

Add

Compare

Today's Range

$9.60

Now: $9.80▼

$9.80

50-Day Range

$7.50

MA: $8.44▼

$10.00

52-Week Range

$4.52

Now: $9.80▼

$11.00

Volume1,345 shs

Average Volume10,716 shs

Market Capitalization$73.95 million

P/E Ratio24.50

Dividend YieldN/A

Beta0.29

Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, kidney, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was founded in 1989 and is headquartered in Oldsmar, Florida.

Headlines

Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2020
February 24, 2021 | finance.yahoo.com

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2020 Financial Results
October 15, 2020 | benzinga.com

Insider Buys Cryo-Cell International Stock
July 17, 2020 | www.benzinga.com

Cord Blood Banking Leader Cryo-Cell Enters into Patent Option Agreement with Duke University
June 11, 2020 | finance.yahoo.com

Cryo-Cell International Inc.
June 7, 2020 | www.marketwatch.com

Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2020 Financial Results
April 14, 2020 | finance.yahoo.com

SHAREHOLDER ALERT: Lundin Law PC Announces Ongoing Investigation Of Cryo-Cell International, Inc. And Advises Investors With
February 28, 2020 | www.bloomberg.com

Cryo-Cell Reports Financial Results For Fiscal Year Ended November 30, 2019
February 27, 2020 | finance.yahoo.com

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2019 Financial Results
October 15, 2019 | finance.yahoo.com

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2019 Financial Results
July 15, 2019 | finance.yahoo.com

Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2019 Financial Results
April 15, 2019 | finance.yahoo.com

Cryo-Cell International Inc
March 19, 2019 | www.bloomberg.com

Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2018
February 28, 2019 | finance.yahoo.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange OTCMKTS

Industry Miscellaneous health & allied services, not elsewhere classified

Sub-IndustryN/A

SectorMedical

Current SymbolOTCMKTS:CCEL

Previous Symbol

CUSIPN/A

CIK862692

Webwww.cryo-cell.com

Phone813-749-2100

Employees87

Year FoundedN/A

Debt

Debt-to-Equity RatioN/A

Current Ratio1.16

Quick Ratio1.08

Price-To-Earnings

Trailing P/E Ratio24.50

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$31.80 million

Price / Sales2.33

Cash Flow$0.45 per share

Price / Cash Flow21.68

Book Value($0.89) per share

Price / Book-11.01

Profitability

EPS (Most Recent Fiscal Year)N/A

Net Income$2.29 million

Net Margins10.39%

Return on Equity-58.74%

Return on Assets7.30%

Miscellaneous

Outstanding Shares7,546,000

Market Cap$73.95 million

Next Earnings Date4/13/2021 (Estimated)

OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

1.04 out of 5 stars

Medical Sector

980th out of 1,968 stocks

Miscellaneous Health & Allied Services, Not Elsewhere Classified Industry

10th out of 25 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Cryo-Cell International.

2.3 Community Rank

Outperform Votes
Cryo-Cell International has received 50 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Cryo-Cell International has received 58 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Cryo-Cell International has received 53.70% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Cryo-Cell International and other stocks. Vote “Outperform” if you believe CCEL will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CCEL will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Cryo-Cell International does not currently pay a dividend.
Dividend Growth
Cryo-Cell International does not have a long track record of dividend growth.

1.7 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Cryo-Cell International insiders have bought more of their company's stock than they have sold. Specifically, they have bought $103,860.00 in company stock and sold $0.00 in company stock.
Percentage Held by Insiders
53.80% of the stock of Cryo-Cell International is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 0.98% of the stock of Cryo-Cell International is held by institutions.

1.3 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Cryo-Cell International is 24.50, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 32.44.
Price to Earnings Ratio vs. Sector
The P/E ratio of Cryo-Cell International is 24.50, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 39.85.

See Top Rated MarketRank™ Stocks Here

$9.80

+0.20 (+2.08 %)

(As of 03/3/2021 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive CCEL News and Ratings via Email

Sign-up to receive the latest news and ratings for CCEL and its competitors with MarketBeat's FREE daily newsletter.

Cryo-Cell International (OTCMKTS:CCEL) Frequently Asked Questions

What stocks does MarketBeat like better than Cryo-Cell International?

Wall Street analysts have given Cryo-Cell International a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Cryo-Cell International wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Cryo-Cell International?

Cryo-Cell International saw a increase in short interest during the month of February. As of February 12th, there was short interest totaling 7,700 shares, an increase of 1,183.3% from the January 28th total of 600 shares. Based on an average daily volume of 6,000 shares, the short-interest ratio is presently 1.3 days.
View Cryo-Cell International's Short Interest.

When is Cryo-Cell International's next earnings date?

Cryo-Cell International is scheduled to release its next quarterly earnings announcement on Tuesday, April 13th 2021.
View our earnings forecast for Cryo-Cell International.

How were Cryo-Cell International's earnings last quarter?

Cryo-Cell International, Inc. (OTCMKTS:CCEL) released its earnings results on Tuesday, October, 15th. The company reported $0.13 earnings per share for the quarter. The firm had revenue of $8.20 million for the quarter. Cryo-Cell International had a negative trailing twelve-month return on equity of 58.74% and a net margin of 10.39%.
View Cryo-Cell International's earnings history.

How has Cryo-Cell International's stock price been impacted by COVID-19 (Coronavirus)?

Cryo-Cell International's stock was trading at $7.20 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, CCEL stock has increased by 36.1% and is now trading at $9.80.
View which stocks have been most impacted by COVID-19.

Who are Cryo-Cell International's key executives?

Cryo-Cell International's management team includes the following people:

Mr. David I. Portnoy, Chairman & Co-CEO (Age 58, Pay $652.09k)
Mr. Mark L. Portnoy, Co-Chief Exec. Officer (Age 57, Pay $519k)
Ms. Jill M. Taymans, CFO & VP of Fin. (Age 51, Pay $201.5k)
Mr. Oleg Mikulinsky, Chief Information Officer (Age 48, Pay $258.33k)
Dr. Merri Buff Mair, Medical Director & Member of Medical & Scientific Team

Who are some of Cryo-Cell International's key competitors?

Some companies that are related to Cryo-Cell International include Baudax Bio (BXRX), GreenVision Acquisition (GRNV), Emmaus Life Sciences (EMMA), Curative Biotechnology (CTYX), Caladrius Biosciences (CLBS), Pacific Health Care Organization (PFHOD), BioRestorative Therapies (BRTXQ), BioRestorative Therapies (BRTX), Pacific Health Care Organization (PFHO), American Caresource (GNOW), Hybrid Energy (HYBE) and QMed (QMED).
View all of CCEL's competitors.

What other stocks do shareholders of Cryo-Cell International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cryo-Cell International investors own include NVIDIA (NVDA), Overstock.com (OSTK), Avid Technology (AVID), The Boeing (BA), Enphase Energy (ENPH), OPKO Health (OPK), Riot Blockchain (RIOT), Aldeyra Therapeutics (ALDX), Alimera Sciences (ALIM) and Allena Pharmaceuticals (ALNA).

What is Cryo-Cell International's stock symbol?

Cryo-Cell International trades on the OTCMKTS under the ticker symbol "CCEL."

How do I buy shares of Cryo-Cell International?

Shares of CCEL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cryo-Cell International's stock price today?

One share of CCEL stock can currently be purchased for approximately $9.80.

How much money does Cryo-Cell International make?

Cryo-Cell International has a market capitalization of $73.95 million and generates $31.80 million in revenue each year.

How many employees does Cryo-Cell International have?

Cryo-Cell International employs 87 workers across the globe.

What is Cryo-Cell International's official website?

The official website for Cryo-Cell International is www.cryo-cell.com.

Where are Cryo-Cell International's headquarters?

Cryo-Cell International is headquartered at 700 Brooker Creek Boulevard Suite 1800, Oldsmar FL, 34677.

How can I contact Cryo-Cell International?

Cryo-Cell International's mailing address is 700 Brooker Creek Boulevard Suite 1800, Oldsmar FL, 34677. The company can be reached via phone at 813-749-2100.

This page was last updated on 3/4/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here